Home » Archive by Tags

Articles tagged with: NSPH

FDA Update and Applications Awaiting Approval (CTIC NSPH, AUXL)
08/27/2009 – 9:51 am PDT | One Comment

Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) recently released their second quarter figures for 2009 and stated it was a transforming quarter for the company, in which they eliminated 44.5% of their outstanding debt. They also released …

FDA decision scheduled for Nanosphere and Advanced Life Sciences (NSPH, ADLS, INO)
07/31/2009 – 6:00 am PDT | One Comment

In the first quarter of 2009 Nanosphere, Inc. (NSPH) filed a de novo 510(k) submission for a hereditary hemochromatosis (”HFE”) genetic test. Mutations of this HFE gene are the leading cause of an iron overload disease. Nanosphere’s test …